Background and Aims: Crohn’s disease (CD) is a chronic inflammatory bowel disease characterized by gastrointestinal inflammation, with gut microbiota dysbiosis playing a key role in its onset and progression. This study aimed to evaluate whether 1-kestose supplementation modulate...
Open access
Research Article10.9734/mrji/2026/v36i31718
Background & Aims: Age-related variation in the gut microbiota complicates biomarker discovery for pancreatic cancer. This study aimed to identify microbial taxa with minimal age dependence that are associated with pancreatic neoplasia and to develop a practical quantitative...
Open access
Research Article10.9734/mrji/2026/v36i41737
Aims: To evaluate the diagnostic potential of previously reported (5ar, nan) and novel microbial gene markers in fecal and salivary microbiomes for the non-invasive detection of colorectal cancer (CRC) progression. Study Design: Cross-sectional study. Place and Duration of Study:...
Open access
Research Article10.9734/mrji/2026/v36i41730
Aims: To characterize fecal gut microbiota features associated with a history of aggression in dogs and to explore whether supplementation with the prebiotic fructooligosaccharide 1-kestose is associated with alterations in gut microbiota composition and owner-reported aggression...
Open access
Research Article10.9734/mrji/2026/v36i21705
Aim: This study aimed to establish a non-invasive, rapid, and cost-effective method to assess the potential risk of immune and psychiatric disorders by quantifying nan gene levels in gut microbiota, specifically focusing on Ruminococcus gnavus and other Lachnospiraceae species as...
Open access
Research Article10.9734/mrji/2024/v34i111503
Aims: Feline atopic skin syndrome (FASS) is a chronic inflammatory skin disease characterized by pruritus and typical lesions such as erythema, papules, excoriations, and lichenification. Although the relationship between gut microbiota and atopic dermatitis is well-documented in...
Open access
Research Article10.9734/mrji/2025/v35i101643